ADAPTIMMUNE THERAPEUTICS PLC
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2016 | — | $218.9M | $163.8M |
| Jun 2016 | — | $197.0M | $150.9M |
| Sep 2016 | — | $180.0M | $140.4M |
| Dec 2016 | — | $166.1M | $158.8M |
| Mar 2017 | — | $208.3M | $170.6M |
| Jun 2017 | — | $229.5M | $122.0M |
| Sep 2017 | — | $229.0M | $145.3M |
| Dec 2017 | — | $203.0M | $84.0M |
| Mar 2018 | — | $191.7M | $53.4M |
| Jun 2018 | — | $165.1M | $42.3M |
| Sep 2018 | — | $276.2M | $153.1M |
| Dec 2018 | — | $246.9M | $68.4M |
| Mar 2019 | — | $219.7M | $49.9M |
| Jun 2019 | — | $187.0M | $34.6M |
| Sep 2019 | — | $147.7M | $39.4M |
| Dec 2019 | — | $123.6M | $50.4M |
| Mar 2020 | — | $186.0M | $86.4M |
| Jun 2020 | — | $407.6M | $122.4M |
| Sep 2020 | — | $376.2M | $78.5M |
| Dec 2020 | — | $341.2M | $56.9M |
| Mar 2021 | — | $309.2M | $32.4M |
| Jun 2021 | — | $277.9M | $50.5M |
| Sep 2021 | — | $241.0M | $42.9M |
| Dec 2021 | — | $206.0M | $149.9M |
| Mar 2022 | — | $163.1M | $89.5M |
| Jun 2022 | — | $141.9M | $97.8M |
| Sep 2022 | — | $113.3M | $79.0M |
| Dec 2022 | — | $81.9M | $108.0M |
| Mar 2023 | — | $83.9M | $119.9M |
| Jun 2023 | — | $126.7M | $77.0M |
| Sep 2023 | — | $88.1M | $90.1M |
| Dec 2023 | — | $39.5M | $144.0M |
| Mar 2024 | — | $24.4M | $140.7M |
| Jun 2024 | $25.0M | $96.3M | $211.8M |
| Sep 2024 | $49.9M | $80.0M | $116.7M |
| Dec 2024 | $50.2M | $11.8M | $91.1M |
| Mar 2025 | $25.4M | $-37.4M | $41.1M |
| Jun 2025 | $25.7M | $-71.0M | $26.1M |